{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Princeton",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81936",
      "recalling_firm": "Dr. Reddy's Laboratories, Inc.",
      "address_1": "107 College Rd E",
      "address_2": "N/A",
      "postal_code": "08540-6623",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0389-2019",
      "product_description": "Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count  bottles, Rx only, Manufactured by: Teva  Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10",
      "product_quantity": "118 bottles",
      "reason_for_recall": "Presence of Foreign Substance: Product complaint of black speckles observed on tablets.",
      "recall_initiation_date": "20190115",
      "center_classification_date": "20190122",
      "termination_date": "20200303",
      "report_date": "20190130",
      "code_info": "Lot #: 43E021 and 43E023, Exp. 01/2020"
    }
  ]
}